Embecta Corp. (EMBC) Securities Class Action: Embecta is a global medical device company whose core business product is pen needles – sterile, single-use, medical devices, designed to be used in ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Earlier this year it appeared that Embecta, a diabetes care company that spun off from BD in 2022, was finally back on track after a rocky 2025. The Parsippany, NJ-based company’s fiscal ...
Good day, and thank you for standing by. Welcome, ladies and gentlemen, to the Embecta Fiscal First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Embecta Corp (ISIN: US29082K1051), a global leader in insulin delivery devices, operates independently in the expanding diabetes management market. North American investors should monitor its product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results